• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Interleukin Genetics to Host Fourth Quarter and Fiscal 2006 Financial Results Conference Call on March 15

Posted on: Monday, 5 March 2007, 09:01 CST

Interleukin Genetics, Inc. (AMEX: ILI) today announced that it will release its fourth quarter and year-end financial results on Thursday, March 15 after the market closes. The Company's management will host the conference call at 4:30 PM EDT to review Interleukin's 2006 year-end financial results and provide management updates.

Conference Call Details

To access the live call on March 15, 2007 at 4:30 PM EDT, dial (800) 817-4887 (domestic) or (913) 981-4913 (international). The call will also be available live via webcast at www.ilgenetics.com.

Replay access of the teleconference will be available for two weeks following the call by calling (719) 457-0820 (domestic) or (888) 203-1112 (international). The passcode for the replay is 5456667. The webcast will be archived following the call at www.ilgenetics.com.

About Interleukin

Interleukin Genetics is a personalized health company primarily focused on the role that genetically determined variations in the inflammatory response has on health and disease.

Interleukin Genetics has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. In addition, Interleukin's Alan James Group subsidiary sells nutraceutical brands, including Ginkoba™, Ginsana™, and Venastat™ through the nation's largest food, drug and mass retailers. Interleukin's current development programs focus on osteoporosis and weight management genetic risk assessment tests, as well as its new proprietary OTCeutical™ products for distribution through the Alan James Group.

For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2005 filed with the Securities and Exchange Commission, our quarterly reports on Form 10-Q and other filings made by us with the Securities and Exchange Commission. We disclaim any obligation or intention to update these forward-looking statements.

Source: Business Wire

More News in this Category